Global Platelet Function Testing Market – Industry Trends and Forecast to 2030

Global Platelet Function Testing Market, By Product (Systems, Reagents and Accessories), Applications (Research, Clinical, Pharmaceutical Development and Others), Testing Type (Light Transmission Aggregometry (LTA), Vasodilator-Stimulated Phosphoprotein (VASP), Multiplate Analyzer (Multiple Electrode Aggregometry (MEA), End User (Hospitals, Blood Banks, Diagnostic Centres, Academic Institutions and Others) – Industry Trends and Forecast to 2030.

Platelet Function Testing Market Analysis and Size

During the forecast period, there may be a rise in demand for platelet function tests due to the increasing prevalence of platelet disorders like thrombocytopenia and thrombocythemia. Globally, the geriatric population is also growing significantly. Therefore, this factor may present the market for platelet function tests with promising growth prospects.

Data Bridge Market Research analyses that the platelet function testing market which was USD 1178.4 million in 2022, is expected to reach USD 1994.63 million by 2030, at a CAGR of 6.8% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Platelet Function Testing Market Scope and Segmentation

Market Definition

Platelets in blood cells play an important role. Platelets form blood clots over damaged blood vessels. Platelets bind together the area around the damaged blood vessels and form a blood clot, preventing blood loss. Platelet function testing is thus a medical procedure used to diagnose any disorders involving blood platelets. Platelet function testing is used to identify issues with platelet production and function. Platelet function testing, in other words, is performed to determine whether or not the platelets are performing optimally. The human body requires an adequate number of platelet cells to perform the clotting process efficiently. Platelet function testing is thus used to assess the balance of platelet cells in the human body.

Global Platelet Function Testing Market Dynamics

Drivers

• Expansion of regulatory authority approvals

The expansion of regulatory authority approvals will favourably impact market growth. For instance, Sysmex Corporation gained zation for in vitro diagnostic use in August 2015 to manufacture three platelet aggregation agonist reagent kits. With greater efficiency and standardization, this kit is used to test platelet aggregation. Tests for platelet aggregation allow researchers to better understand the platelets, which are crucial to hemostasis. The antiplatelet therapy used to treat arterial thrombotic disorders is monitored with this test kit, which is also used to diagnose thrombasthenia.

• Rising early detection of platelet disorders

A platelet function test is necessary to determine whether or not a person has a platelet function abnormality. The entire body's process depends on platelet function. Early detection is the key to treating diseases and platelet abnormalities. These elements may therefore offer the platelet function testing market significant growth potential.

The prevalence of platelet disorders such as thrombocytopenia and thrombocythemia may increase demand for platelet function tests during the forecast period. The elderly population worldwide is also increasing quickly, the market for platelet function testing may experience appealing development opportunities.

Opportunities

• Growing incidence of platelet disorders

The platelet function test is in high demand due to the increasing prevalence of platelet diseases. The rising prevalence of diseases such as thrombocythemia (an abnormal increase in the number of platelets) and thrombocytopenia (a decrease in the number of platelets) is drive the platelet function testing market during the forecast period. Platelet function abnormalities are 1.5 times more likely to develop in women and the elderly. With the increasing global life expectancy rate, there is an increase in the patient pool requiring platelet function test, which is expected to increase demand for platelet function testing market.

Restraints/Challenges

• Unfavourable Reimbursement Regulations

The growth of the platelet function test market will be hampered by unfavourable reimbursement regulations in emerging markets. Furthermore, a lack of qualified specialists or educated knowledge in developing and underdeveloped economies may slow the growth rate of the platelet function test market.

This platelet function testing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the platelet function testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In April 2019, Aggredyne, Inc., a platelet testing and research company, received FDA clearance for its novel AggreGuide A-100® ADP Assay testing cartridge, a low-cost in vitro diagnostic instrument used to assess the efficacy of numerous antiplatelet drugs that target the platelet P2Y12 receptor.

Global Platelet Function Testing Market Scope

The platelet function testing market is segmented on the basis of product, applications, testing type and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Systems
• Reagents
• Accessories

 Applications

• Research
• Clinical
• Pharmaceutical Development
• Others

 Testing Type

• Light Transmission Aggregometry (LTA)
• Vasodilator-Stimulated Phosphoprotein (VASP)
• Multiplate Analyzer (Multiple Electrode Aggregometry (MEA)

 End User

• Hospitals
• Blood Banks
• Diagnostic Centres
• Academic Institutions
• Others

Platelet Function Testing Market Regional Analysis/Insights

The platelet function testing market is analyzed and market size insights and trends are provided by country, product, applications, testing type and end user as referenced above.

The countries covered in the platelet function testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the platelet function testing market due to the rising occurrence of platelet disorders and prevalence of advanced healthcare technologies.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 because of the rising expenditure of healthcare infrastructure, rising cases of cancer and rising awareness about platelet function testing technology.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The platelet function testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for platelet function testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the platelet function testing market. The data is available for historic period 2011-2021.

Competitive Landscape and Platelet Function Testing Market Share Analysis

The platelet function testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to platelet function testing market.

Some of the major players operating in the platelet function testing market are:

• F. Hoffmann-La Roche Ltd (Switzerland)
• Fresenius SE & Co. KGaA (Germany)
• Siemens (Germany)
• Terumo Corporation (U.S.)
• Haemonetics Corporation (U.S.)
• AggreDYNE (U.S.)
• Helena Laboratories (U.S.)
• Sysmex Corporation (Japan)
• Haemochrom Diagnostica GmbH (Germany)
• Pathway Diagnostics Limited (U.K.)
• LABiTec LAbor BioMedical Technologies GmbH (Germany)
• Thermo Fisher Scientific Inc. (U.S.)
• Quest Diagnostics Incorporated (U.S.)
• PerkinElmer Inc. (U.S.)
• Werfen, S.A. (Spain)
• Matis Medical Inc. (U.S.)